Drug Trial Radar · NCT03811535
A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4)
Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
May 20, 2019
Primary completion
Nov 10, 2021
Study completion Sep 30, 2025
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Jan 22, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study compares 2 medicines for children who do not have enough hormone to grow: somapacitan given once a week (a new medicine) and Norditropin® given once a day (the medicine doctors can already prescribe). Researchers will test to see how well somapacitan works. The study will also test if somapacitan is safe. Participants will either get somapacitan or Norditropin® - which treatment participants get, is decided by chance. Both participants and the study doctor will know which treatment participants get. The study will last for 4 years. Participants will attend 19 clinic visits and have 1 phone call with the study doctor.
Conditions
- Growth Hormone Deficiency in Children
Interventions
SomapacitanDrug
Somapacitan will be administered subcutaneously (s.c.; under the skin) once weekly by PDS290 pen-injector. Somapacitan can be injected any time during the once weekly dosing day. The dose will be calculated based on the subject's current body weight.
Norditropin®Drug
Norditropin® will be administered s.c. once daily by FlexPro® pen-injector. Norditropin® should be injected daily in the evening. The dose will be calculated based on the subject's current body weight.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Height Velocity: In-trial Observation PeriodTime frame: From baseline (week 0) to visit 7 (week 52)
- Height Velocity: On-treatment Observation PeriodTime frame: From baseline (week 0) to visit 7 (week 52)
Locations
139 sites in 26 countries. Site status is shown where the registry gives one.
Univ of AL at Birmingham_BRM
Birmingham, Alabama
Children's Hospital Los Angeles - Endocrinology
Los Angeles, California
Valley Children's Hospital
Madera, California
Children's Hosp Of Orange
Orange, California
Sutter Valley Med Fdt Ped Endo
Sacramento, California
Rocky Mt Ped and Endo
Centennial, Colorado
Ped Endo Assoc PC-G.V
Greenwood Village, Colorado
Yale-New Haven Hospital
New Haven, Connecticut
A.I. duPont Hospital for Children/Nemours
Wilmington, Delaware
Pediatric Endocrine & Wellness Center
Aventura, Florida
Van Meter Pediatric Endo PC
Atlanta, Georgia
Riley Hospital For Children
Indianapolis, Indiana
University OF Iowa
Iowa City, Iowa
Univ of Minnesota M.C.H.
Minneapolis, Minnesota
Children's Minnesota
Saint Paul, Minnesota
Children's Mercy Clinics
Kansas City, Missouri
The Docs
Las Vegas, Nevada
Goryeb Children's Hospital
Morristown, New Jersey
UBMD Peds-Div of Endo/Diabetes
Buffalo, New York
NYU Langone Hospital-LI
Mineola, New York
WakeMed Childn Endo-Dbt_Raleig
Raleigh, North Carolina
CCHMC_Cinc
Cincinnati, Ohio
Univ Oklahoma Sci Ctr OK City
Oklahoma City, Oklahoma
UPMC Child Hosp-Pittsburgh
Pittsburgh, Pennsylvania
Dell Children's Medical Center
Austin, Texas
Cook Children's Medical Center
Fort Worth, Texas
MultiCare Inst for Res & Innov
Tacoma, Washington
CHU Bab El Oued Pediatrics Dept
Algiers, Algeria
Endo and Diab Dept El Oued
Algiers, Algeria
endocrino-diabetology department, Hospital IBN BADIS.
Constantine, Algeria
Med. Univ. Graz -Klinische Abteilung f. Allgemeine Pädiatrie
Graz, Austria
LKH Salzburg- Univ. Klinik f. Kinder- und Jugendheilkunde
Salzburg, Austria
LKH St. Poelten, Kinder-und Jugendheilkunde
Sankt Pölten, Austria
Salzkammergut-Klinikum Vöcklabruck
Vöcklabruck, Austria
Stollery Children's Hospital
Edmonton, Alberta, Canada
Mntrl Chldrn Hsptl PedEndoMUHC
Montreal, Quebec, Canada
Rigshospitalet Klinik for Vækst og Reproduktion Afsnit 5064
Copenhagen Ø, Denmark
Tallinn Children's Hospital
Tallinn, Estonia
Tartu University Hospital Children's Clinic
Tartu, Estonia
Centre Hospitalier Universitaire D'Angers-2
Angers, France
Showing 40 of 139 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.